extraction with diethyl ether and chromatographic separation of steroids, we measured concentrations of salivary and plasma dehydroepiandrosterone (DHEA) in 22 women with normal ovulatory cycles (ages 18-45 years). Salivary DHEA values closely correlated with total and free DHEA in plasma. In the follicular phase the mean concentrations of salivary and plasma free DHEA were virtually equal [mean (SD): 0.61 (0.32) and 0.56 (0.34) nmol/L, respectively]. In the luteal phase, salivary OHEA slightly exceeded the plasma free DHEA [0.68 (0.40) vs 0.56 (0.38) nmol/L, P <0.01]. Also, dunng combined dexamethasone/synthetic corticotropin administration in 25 patients with androgenizing disorders and in 10 normal subjects (each in the follicular and luteal phases), the concentration of DHEA in saliva strongly correlated with total and free OHEA in plasma. During these dynamic tests, the mean concentrations of free DHEA in plasma and salivary DHEA in the hirsute women were significantly higher than the mean concentrationsin the control women at all times before and after corticotropin infusion(P <0.05-<0.0001). In contrast, plasma total DHEA in patients exceeded nonhirsute values only at 15 mm after corticotropin administration. In six of 25 patients total DHEA during combined administration of dexamethasone/synthetic corticotropin exceeded normal values by at least 2 SD. The response of salivary and free DHEA to synthetic corticotropin in this subgroup was also excessive. Assessment of steroids in saliva has been advocated as a convenient alternative to the measurement of (free) steroids in plasma (9) (10) (11) (12) (13) (14) . For several steroids the concentration in saliva correlates well with the concentration of the free steroid in plasma (11, 13, 15, 16). Moreover, this approach allows a stress-free multiple sampling regime, which is especially important in assessing the concentrations of adrenal steroid hormones and other hormones whose plasma concentrations are influenced by stress and by diurnal rhythm.
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Dehydroepiandrosterone (DHEA) is a C19 steroid hormone primarily of adrenal origin (1, 2) . Measurement of total DHEA in plasma of mild hyperandrogenemic women has often been advocated to determine whether the adrenals or the ovary is the source of androgen overproduction.
An excessive DHEA response during combined administration of dexamethasone/synthetic corticotropin points to adrenal androgen overproduction (3). DHEA is strongly bound to plasma proteins, mainly albumin and sex-hormone-binding globulin (SHBG) (4). In hirsute patients the concentration of SHBG is often decreased (5, 6) . Therefore, assessment of total DHEA in plasma may be less informative than is the measurement of free DHEA. The concentrations of free steroids in blood correlate well with the hormonal status (7, 8) , but reliable measurements of free hormone concentrations are often complicated and time-consuming.
Assessment of steroids in saliva has been advocated as a convenient alternative to the measurement of (free) steroids in plasma (9) (10) (11) (12) (13) (14) . For several steroids the concentration in saliva correlates well with the concentration of the free steroid in plasma (11, 13, 15, 16) . Moreover, this approach allows a stress-free multiple sampling regime, which is especially important in assessing the concentrations of adrenal steroid hormones and other hormones whose plasma concentrations are influenced by stress and by diurnal rhythm.
Data concerning measurements of salivary DHEA are very scarce, and dynamic studies are completely lacking.
We have developed a radioimmunoassay of DHEA in saliva. To evaluate this analyte as an androgen marker and to investigate whether salivary DHEA reflects the concentration of free (and total) DHEA in plasma, we determined the concentration of salivary DHEA under normal conditions and during combined administration of dexamethasone/synthetic corticotropin in normal women and women with androgenizing disorders.
MaterIalsand Methods

Subjects and Sampling
Matched specimens of plasma and mixed whole saliva were obtained from 22 After 6 mm at 4#{176}C the samples were centrifuged at 2000 x g for 10 mm at 4 #{176}C. The supernates were decanted simultaneously into counting vials, by use of the equipment described by Vecsei and Gless (18) . After adding 4 mL of scintillation cocktail (Aqua Luma; Lumac LSC By, Olen, Belgium), we determined each sample's radioactivity.
The anti-DHEA antiserum had been raised in Texel White sheep against DHEA-17-carboxymethyloxime conjugated to bovine serum albumin.
We mixed 0.5 mL of the conjugate (1 g/L) with an equal volume of Freund's complete adjuvant (Behringwerke AG, Marburg, F.R.G.), emulsified this, and injected it into the sheep subcutaneously each two weeks for four months. The antiserum titer was 1:60 000.
Free DHEA in Plasma
To assess free DHEA in plasma, we subjected samples to equilibrium dialysis with Diachema dialysis equipment (Diachema AG, Rtischlikon-Z#{252}rich, Switzerland) and Visking dialysis membranes (exclusion limit 8-15 kDa) as described previously for free androstenedione in plasma (15) . In short, tritiated DHEA was purified by paper chromatography in a modified Bush A system (as described above). The tracer was eluted with 100% ethanol. Aliquots containing 30000 dpm of [3HIDHEA were evaporated under a stream of nitrogen. We added 300 j.tL of undiluted plasma sample to the residue and incubated it for 30 mm at 37 #{176}C. An aliquot of 180 pL of this incubate was pipetted into half of a dialysis cell and dialyzed for 4 h at 37 #{176}C against 180 L of 50 mmol/L phosphate buffer-0.1 mol!L NaCl solution, pH 7.4.
To measure the total radioactivity, we counted the radioactivity of duplicate 50-p.L aliquots of the plasma incubate. After determinating the radioactivity in the dialysate, we calculated the percentage of free DHEA in the undiluted sample.
Indirect equilibrium dialysis for the assessment of free DHEA was validated by comparison with the assessment of free DHEA in plasma dialysates by RIA. For this we dialyzed 1.0 mL of plasma for 4 hat 37 #{176}C against 1.0 mL of the phosphate buffer in NaCl solution.
The concentration of DHEA in the dialysate was measured by RIA as described above. The concentration of free DHEA in the undiluted sample (F0) was calculated according to the formula: F0 = H0/[(HjF) -(V/V0) + 11, where H is the total concentration of DHEA in the sample; F, the concentration of free DHEA in the dialysate; V, the total volume of the dialysis system; and V0, the original sample volume.
Statistical Analysis
For comparison of means we used the unpaired Student's t-test adjusted for unequal variances where necessary; correlations were evaluated with the Spearman rank correlation test, unless stated otherwise.
Results
DHEA Radloimmunoassay in Plasmaand Saliva
The lower limit of detection of the DHEA assay, defined as the least amount of DHEA distinguishable from zero at a 95% confidence limit, was 5 fmol per tube. The mean recovery of the extraction and chromatography procedure (56.6% ± 5.9%, n = 100) corresponds to a sensitivity of 30 pmol/L when 1 mL of plasma or saliva was assayed. The assay blank corresponded to 3 pmol!L.
Assay of 100-, 200-, and 300-tL aliquots of the eluate showed a linear relationship between the eluate volume and the amount of DHEA. The anti-DHEA antiserum showed complete cross-reactivity with androstenediol. Although the normal concentration of DHEA in plasma is greater than that of androstenediol, interference from the latter in a direct RIA might be expected. However, androstenediol (RIO. 19) was effectively separated from DHEA (Rf 0.50) by paper chromatography in the modified Bush A system. There was no significant cross-reactivity with other relevant steroid hormones. The intra-assay CV, calculated as the relative duplicate variation, was 5.1% in saliva samples with DHEA concentrations of 0.10 to 1.50 nmollL (n = 100) and 4.8% in plasma samples with a concentration range of 1.50 to 10.0 nmollL (n = 100). The interassay CV at a mean concentration of 13.0 nmol/L was 7.6% (n = 22).
Validation of Free DHEA Assessments by Indirect Equilibrium Dialysis
The concentration of free DHEA in plasma assessed by the indirect method (y) correlated well with the concentration of free DHEA determined by direct equilibrium dialysis (x), i.e., by REA of DHEA in plasma dialysates (Pearson regression analysis: y = 1.Olx + 0.04 nmol/L, r = 0.988, P <0.001, n = 40).
Salivary OHEA in Normal Women under Basal Conditions
In the 22 women with normal menstrual cycles, the difference between luteal-and follicular-phase concentrations of the plasma total, plasma free, and salivary DHEA during the menstrual cycle was not statistically significant.
In the follicular phase, the concentration of salivary DHEA was not significantly different from that of free DHEA in plasma. However, in the luteal phase of the cycle, the concentration of salivary DHEA slightly exceeded that of free DHEA in plasma (P <0.01, paired Student's t-test, Table 1 ). In both phases salivary DHEA concentrations correlated very strongly with concentrations of free and total DHEA in plasma.
In each individual the concentrations of DHEA in plasma and saliva in the follicular phase were remarkably similar to those in the luteal phase of the cycle. The correlation between plasma total DHEA (r = 0.740), plasma free DHEA (r = 0.700), and salivary DHEA concentrations (r = 0.787) in the follicular phase on the one hand and the luteal phase on the other was highly significant (P <0.01).
In a normal woman, we studied the diurnal rhythm of DHEA and found a distinct diurnal variation of total DHEA, with morning values threefold that of the afternoon concentrations.
This diurnal pattern was closely reflected by the concentrations of free DHEA in plasma and of salivary DHEA. The DHEA rhythm coincided with the variation of cortisol during the day (r = 0.749, P <0.01, and r = 0.855, P <0.01, respectively, Figure 1 ).
Administration of Combined Dexamethasone/Synthetic
Corticotropin Basal dexamethasone-suppressed concentrations of DHEA in plasma and saliva were low during adininistration of combined dexamethasone/symthetic corticotropin in controls and hirsute women, though significantly higher in the latter (P <0.05). After administration of synthetic corticotropin, stimulation peaks were observed at 45-75 mm (Table 2 ). There was no significant difference in the plasma cortisol responses between normal women and patients (data not shown). In the control women, increases (0.82) nmoIfL, respectively (P <0.01). There was a strong correlation (P <0.01) between plasma total, plasma free, and salivary DHEA in the controls as well as in hirsute women at the different intervals after stimulation. The mean total DHEA response was significantly higher in the patients than in the controls 15 mm after infusion of synthetic corticotropin.
However, the mean plasma free
DHEA and the mean salivary DHEA were significantly higher in the group of patients at all intervals after corticotropin (P <0.05-<0.001, Table 2 ).
At 15, 45, and 75 mm after administration of synthetic corticotropin, total plasma DHEA concentrations for six patients exceeded the mean response of the controls by >2
SD. In this subgroup of"high-responders" at each sampling time, salivary and free DHEA were also significantly higher than the corresponding DHEA in controls (P <0.01).
In the remaining 19 women ("normal responders"), basal total DHEA and the responses to corticotropin were not obviously different from those of the control women. Plasma free DHEA, however, was significantly higher than in the controls at all intervals, the salivary DHLEAonly at 15 mm (Table 2) .
Discussion
The aim of this study was to develop an RIA for assessing salivary DHEA, to evaluate the usefulness of this analyte as an index of adrenal androgen output. DHEA proved to be readily measurable in saliva. Free DHEA was measured by indirect equilibrium dialysis. The radiochemical purity of the tracer used in this technique is critically important. We observed androstenedione hyperresponsiveness after corticotropin administration in three of the six DHEA hyperresponders (unpublished observation).
In conclusion, the data here illustrate that the concentration of DHEA in saliva is a reliable index of adrenal DHEA secretion, allowing a stress-free multiple sampling regime for the study of time-related hormonal events.
